Gene Expression of Glucose Transporter 1 (GLUT1), Hexokinase 1 and Hexokinase 2 in Gastroenteropancreatic Neuroendocrine Tumors: Correlation with F-18-fluorodeoxyglucose Positron Emission Tomography and Cellular Proliferation
Neoplastic tissue exhibits high glucose utilization and over-expression of glucose transporters (GLUTs) and hexokinases (HKs), which can be imaged by 18F-Fluorodeoxyglucose-positron emission tomography (FDG-PET). The aim of the present study was to investigate the expression of glycolysis-associated...
Main Authors: | Andreas Kjaer, Jane Preuss Hasselby, Annika Loft, Birgitte Federspiel, Peter Sommer, Ulrich Peter Knigge, Tina Binderup |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-10-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | http://www.mdpi.com/2075-4418/3/4/372 |
Similar Items
-
[18F]FDG Uptake and PCNA, Glut-1, and Hexokinase-II Expressions in Cancers and Inflammatory Lesions of the Lung
by: Marcelo Mamede, et al.
Published: (2005-04-01) -
Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive Review
by: Emma Elizabeth Ilett, et al.
Published: (2015-04-01) -
A precision therapeutic strategy for hexokinase 1-null, hexokinase 2-positive cancers
by: Shili Xu, et al.
Published: (2018-06-01) -
P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms
by: Kirstine Nielsen, et al.
Published: (2020-01-01) -
Detection of Pacemaker Lead Infection by Fluorodeoxyglucose Positron Emission Tomography
by: Takashi Miura, MD, et al.
Published: (2006-01-01)